Evidence map›Paper›PMID 35938811›Full record

ArticleMicrobiology spectrum2022

Impact of

A Erega, P Stefanic, T Danevčič, S Smole Možina, I Mandic Mulec

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Discovery of Tyrosinase Inhibitors fromCurrent issues in molecular biology · 2026
    Article
  2. Article
  3. Article
  4. Genomic Analysis and Metabolite Profiling of Three ProbioticPreventive nutrition and food science · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

A EregaDepartment of Food Science and Technology, Biotechnical Faculty, University of Ljubljanagrid.8954.0, Ljubljana, Slovenia.ORCID 0000-0002-7932-8855
P StefanicDepartment of Food Science and Technology, Biotechnical Faculty, University of Ljubljanagrid.8954.0, Ljubljana, Slovenia.ORCID 0000-0002-9444-597X
T DanevčičDepartment of Food Science and Technology, Biotechnical Faculty, University of Ljubljanagrid.8954.0, Ljubljana, Slovenia.
S Smole MožinaDepartment of Food Science and Technology, Biotechnical Faculty, University of Ljubljanagrid.8954.0, Ljubljana, Slovenia.ORCID 0000-0001-7949-8128
I Mandic MulecDepartment of Food Science and Technology, Biotechnical Faculty, University of Ljubljanagrid.8954.0, Ljubljana, Slovenia.ORCID 0000-0002-7629-3255
University of Ljubljana · SI

Funding

RAPID DEMOGRAPHIC CHANGE AND WELFARER37AG007637 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HERMALIN, ALBERT I · 1989 to 1998
–
6 · The paper itself

Abstract

The foodborne pathogen Campylobacter jejuni is typically found in an agricultural environment; in animals, such as birds, as an intestinal commensal; and also in food products, especially fresh poultry meat. Campylobacter interactions within mixed species biofilms are poorly understood, especially at the microscale. We have recently shown that the beneficial bacterium Bacillus subtilis reduces C. jejuni survival and biofilm formation in coculture by secreting the antibiotic bacillaene. We extend these studies here by providing evidence that besides bacillaene, the antagonistic effect of B. subtilis involves a nonribosomal peptide bacilysin and that the fully functional antagonism depends on the quorum-sensing transcriptional regulator ComA. Using confocal laser scanning microscopy, we also show that secreted antibiotics influence the distribution of C. jejuni and B. subtilis cells in the submerged biofilm and decrease the thickness of the pathogen's biofilm. Furthermore, we demonstrate that genes encoding structural or regulatory proteins of the efflux apparatus system (

Indexed as

Campylobacter jejuniAnimalsAnti-Bacterial AgentsBacillus subtilisBacterial ProteinsBiofilmsDipeptidesAnti-Bacterial AgentsbacilysinBacterial ProteinsDipeptidesantibioticsbacillaeneBacillus subtilisbacilysinbiofilm formationCampylobacter jejuniefflux pumpssecondary metabolites

Identifiers

PMID35938811
PMCPMC9430781
OpenAlexW4290723707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.